logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Lilly Announces Extension Of Tender Offer To Acquire Dice

Jul 25, 2023•over 2 years ago

Acquiring Company

Eli Lilly

Acquired Company

DICE

IndianapolisLondonManufacturingHealth CareMedia And EntertainmentEvents

Description

Eli Lilly and Company (NYSE: LLY) today announced the extension of the expiration of the tender offer to acquire all of the issued and outstanding shares ("Shares") of common stock of DICE Therapeutics, Inc. (NASDAQ: DICE), for a purchase price of $48 per share in cash, without interest and less any applicable tax withholding.

Company Information

Company

Eli Lilly

Location

Indianapolis, Indiana, United States

About

Eli Lilly is a global healthcare and pharmaceutical company focused on the discovery, development, and delivery of innovative pharmaceutical medicines, vaccines, and consumer healthcare products. It has a strong presence in the diabetes and obesity market segment and has been actively expanding its manufacturing network to meet the increasing demand for its medicines.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed